BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
316.99
-5.38 (-1.67%)
At close: Feb 27, 2026, 4:00 PM EST
317.01
+0.02 (0.01%)
After-hours: Feb 27, 2026, 5:21 PM EST
BeOne Medicines AG Employees
BeOne Medicines AG had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$485,730
Profits / Employee
$26,085
Market Cap
35.17B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BioNTech SE | 6,772 |
| Moderna | 4,700 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| argenx SE | 1,599 |
ONC News
- 2 days ago - BeiGene Non-GAAP EPS of $1.95 beats by $0.65, revenue of $1.5B beats by $50M - Seeking Alpha
- 3 days ago - BeiGene (ONC) Q4 Earnings Preview: Revenue Set for Growth - GuruFocus
- 3 days ago - BeiGene Q4 2025 Earnings Preview - Seeking Alpha
- 10 months ago - U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene - Business Wire
- 11 months ago - BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer - Business Wire